﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Cision News</title><link>https://news.cision.com</link><description>Cision is the leading global provider of media research, distribution, monitoring and evaluation services. With over 40 locations throughout the world, Cision provides the insight, expertise and intelligence that improve performance and build reputations.</description><pubDate>Tue, 09 Jun 2026 12:31:49 GMT</pubDate><image><title>Cision News</title><width>146</width><height>60</height><link>https://news.cision.com</link><url>https://news.cision.com/Content/img/news-logo.png</url></image><item><title>Unilabs York Bioanalytical Solutions Adds Further Technology to Enhance Customer Satisfaction</title><link>http://news.cision.com/unilabs-ab/r/unilabs-york-bioanalytical-solutions-adds-further-technology-to-enhance-customer-satisfaction,c569908</link><guid isPermaLink="false">cision341306</guid><description><![CDATA[Unilabs York Bioanalytical Solutions (YBS) has a history of employing cutting edge technology to maintain its place as Europe’s premier, independent bioanalytical facility. As part of this commitment to providing the latest technology to its clients, YBS is pleased to announce the acquisition of new systems that will help the company énhance its ability to provide high quality bioanalytical data to its clients with increased efficiency.
Two new Waters Xevo TQ-S LC-MS/MS systems will enable the detection and quantification of lower levels of conventional small molecule therapeutics,]]></description><pubDate>Fri, 06 May 2011 08:02:13 GMT</pubDate></item><item><title>Unilabs - York Bioanalytical Solutions, YBS, appoints Mohammed Abrar as Method Development Manager</title><link>http://news.cision.com/unilabs-ab/r/unilabs---york-bioanalytical-solutions--ybs--appoints-mohammed-abrar-as-method-development-manager,c529825</link><guid isPermaLink="false">cision286452</guid><description><![CDATA[- Method development specialist brings more than 20 years of experience within the drug development industry to ensure Unilabs YBS’ position as one of the most significant independent supplier of bioanalysis for NCEs and NBEs as well as biomarkers and sample management in Europe.
Unilabs YBS are pleased to announce that Mohammed Abrar has joined the company as Method Development Manager for LCMS/MS methods. With more than 20 years of method development experience within the drug development industry Mr. Abrar will lead the method development within Unilabs YBS in their York laboratory.]]></description><pubDate>Wed, 01 Dec 2010 08:30:00 GMT</pubDate></item><item><title>Unilabs - York Bioanalytical Solutions, YBS, appoints David J Browne to Business Development Manager</title><link>http://news.cision.com/unilabs-ab/r/unilabs---york-bioanalytical-solutions--ybs--appoints-david-j-browne-to-business-development-manager,c523789</link><guid isPermaLink="false">cision282195</guid><description><![CDATA[- Renowned specialist brings more than 20 years of drug development experience to develop and promote new businesses at YBS in Copenhagen and York.
Unilabs YBS are pleased to announce that David J Browne has joined the company as Business Development Manager. With more than 20 years of experience within the drug development industry, including all aspects of Bioanalysis, Mr. Browne will lead the business development within Unilabs YBS in Copenhagen and York. 

Mr. Browne joins YBS from Covance Laboratories where he served as Laboratory Manager. At Covance he initially specialised in high]]></description><pubDate>Tue, 09 Nov 2010 08:00:00 GMT</pubDate></item><item><title>Unilabs - York Bioanalytical Solutions, YBS, appoints Dr. Viv Willson to strengthen the immunoassay team in Copenhagen</title><link>http://news.cision.com/unilabs-ab/r/unilabs---york-bioanalytical-solutions--ybs--appoints-dr--viv-willson-to-strengthen-the-immunoassay-team-in-copenhagen,c521087</link><guid isPermaLink="false">cision280495</guid><description><![CDATA[Unilabs - York Bioanalytical Solutions, YBS, appoints Dr. Viv Willson to strengthen the immunoassay team in Copenhagen
YBS today announced a new collaboration with Dr.Viv Willson who will be working within the Drug Development Services (DDS) section at Unilabs YBS in Copenhagen.

Dr. Willson’s recent experience in setting up the immunoassay facility at YBS in York and the client contacts he developed as a result will be valuable in developing and promoting new technology in the DDS section in Copenhagen and in applying this to forthcoming drug development projects.

YBS is dedicated to]]></description><pubDate>Tue, 26 Oct 2010 12:00:00 GMT</pubDate></item><item><title>Unilabs Drug Development Services changes brand to York Bioanalytical Solutions</title><link>http://news.cision.com/unilabs-ab/r/unilabs-drug-development-services-changes-brand-to-york-bioanalytical-solutions,c514336</link><guid isPermaLink="false">cision276278</guid><description><![CDATA[In order to develop its position as a leading Independent Bioanalytical CRO in Europe, Unilabs Drug Development Services changes brand to York Bioanalytical Solutions, YBS, as of today.
Yvonne Lech, Managing Director of Unilabs Denmark stated: “Since becoming part of the Unilabs group in May 2008, YBS has integrated with Unilabs Copenhagen to share quality and regulatory competencies & scientists, as well as supplementing each other’s core competencies.

It is now time to introduce a common brand name for Unilabs activities within Drug Development Services.

The “new” Unilabs York]]></description><pubDate>Mon, 27 Sep 2010 07:40:17 GMT</pubDate></item><item><title>Straight to the point: iPOCT first to gain UK accreditation for point-of-care testing</title><link>http://news.cision.com/unilabs-ab/r/straight-to-the-point--ipoct-first-to-gain-uk-accreditation-for-point-of-care-testing,c459851</link><guid isPermaLink="false">cision245070</guid><description><![CDATA[Unilabs iPOCT has become the first laboratory to be granted UK accreditation for point-of-care testing. This accreditation gives confidence in the competence of iPOCT’s innovative, customer-focused testing service, and may ultimately lead to improved clinical care for patients.
iPOCT, a leader in the European diagnostic service industry, worked closely with UKAS (United Kingdom Accreditation Service) and CPA (Clinical Pathology Accreditation) to undergo assessment for the accreditation, which is a key element of building and maintaining confidence in providers of point-of-care testing. Point-]]></description><pubDate>Tue, 24 Nov 2009 08:36:15 GMT</pubDate></item><item><title>Improved Patient Pathway at Wirral Heart Support Centre with iPOCT’s Point of Care Testing System</title><link>http://news.cision.com/unilabs-ab/r/improved-patient-pathway-at-wirral-heart-support-centre-with-ipoct-s-point-of-care-testing-system,c454661</link><guid isPermaLink="false">cision242297</guid><description><![CDATA[Staff at NHS Wirral’s Heart Support Centre are able to offer more effective care for patients following the recent installation of a point of care testing service. Decisions about treatment and medication can be made in a single visit, which may also lead to improved health and lower costs.
Point of care testing (POCT) is an innovative form of testing of patient samples outside a conventional laboratory setting, improving patient flow with rapid turn around time for results and improved access to testing in community care settings. The aim of the co-operation between the Wirral Heart Support]]></description><pubDate>Mon, 26 Oct 2009 12:51:15 GMT</pubDate></item><item><title>Unilabs acquires EuradConsult - adds teleradiology as core competence</title><link>http://news.cision.com/unilabs-ab/r/unilabs-acquires-euradconsult---adds-teleradiology-as-core-competence,c386776</link><guid isPermaLink="false">cision209126</guid><description><![CDATA[In order to develop teleradiology services on a pan-European basis, Unilabs announced today that it has acquired EuradConsult BVBA, a leading provider of teleradiology services.
The combination of Unilabs’ experience in producing radiology examinations and EuradConsult’s experience in teleradiology services will create a strong and attractive high-quality provider with an excellent position in central Europe.
“Teleradiology creates the possibility to increase availability of high quality radiology reporting services, reduce healthcare costs and use limited radiological resources in an]]></description><pubDate>Thu, 16 Oct 2008 12:54:05 GMT</pubDate></item><item><title>Unilabs announces the launch of a new corporate identity</title><link>http://news.cision.com/unilabs-ab/r/unilabs-announces-the-launch-of-a-new-corporate-identity,c379231</link><guid isPermaLink="false">cision206231</guid><description><![CDATA[Unilabs, one of Europe’s leading diagnostic services companies, has unveiled its new corporate identity. The new brand is designed to reflect today’s Unilabs – a customer-oriented company that will become a strong force in the European laboratory and radiology market.
PRESS RELEASE
Geneva Switzerland, 16 September 2008
The rebranding of Unilabs represents a significant step in connection with the integration process following last year’s fusion of Unilabs and Capio Diagnostics, which has created a leading European quality-driven laboratory and radiology service group. Following the]]></description><pubDate>Tue, 16 Sep 2008 07:00:00 GMT</pubDate></item></channel></rss>